Organon & Co.

20.97 USD
-0.01 (-0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Organon & Co. stock is up 0.62% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 July’s closed higher than June. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
23 May 18:35 16 Jan, 2026 7.50 CALL 20 568
13 Jun 18:49 16 Jan, 2026 12.50 CALL 40 259

About Organon & Co.

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies.